The regional fund Créalia is providing support to MB Therapeutics
The seed fund Créalia awards an innovation grant to MB Therapeutics for the development of its personalized medicine solution.
News
MB Therapeutics is labeled as a deep tech company
MB Therapeutics has obtained the Deeptech label from BPI for a personalized medicine manufacturing project using 3D printing.